CUSI, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 16.773
EU - Europa 14.581
AS - Asia 8.308
SA - Sud America 1.517
AF - Africa 573
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 20
Totale 41.806
Nazione #
US - Stati Uniti d'America 16.551
RU - Federazione Russa 3.027
GB - Regno Unito 2.730
CN - Cina 2.704
SG - Singapore 2.528
IT - Italia 2.038
IE - Irlanda 2.022
BR - Brasile 1.258
UA - Ucraina 991
SE - Svezia 962
VN - Vietnam 907
FR - Francia 869
DE - Germania 860
HK - Hong Kong 714
FI - Finlandia 502
KR - Corea 418
ZA - Sudafrica 301
IN - India 267
BD - Bangladesh 137
CA - Canada 116
TR - Turchia 114
ES - Italia 112
IQ - Iraq 92
PL - Polonia 89
NL - Olanda 85
AR - Argentina 79
NG - Nigeria 74
CI - Costa d'Avorio 65
PK - Pakistan 61
BE - Belgio 57
MX - Messico 57
JP - Giappone 54
AT - Austria 51
EC - Ecuador 48
ID - Indonesia 44
CZ - Repubblica Ceca 41
SA - Arabia Saudita 41
CO - Colombia 31
VE - Venezuela 30
KE - Kenya 27
MA - Marocco 26
UZ - Uzbekistan 26
AU - Australia 23
CL - Cile 23
PH - Filippine 20
EU - Europa 19
PE - Perù 19
AE - Emirati Arabi Uniti 16
JO - Giordania 16
LT - Lituania 16
EG - Egitto 15
AL - Albania 13
DZ - Algeria 13
KZ - Kazakistan 13
NP - Nepal 13
TN - Tunisia 13
IL - Israele 12
PT - Portogallo 12
PY - Paraguay 12
PA - Panama 11
RS - Serbia 11
UY - Uruguay 11
IM - Isola di Man 10
MY - Malesia 10
NZ - Nuova Zelanda 10
TH - Thailandia 10
AZ - Azerbaigian 9
CH - Svizzera 9
ET - Etiopia 9
GR - Grecia 9
IR - Iran 9
BG - Bulgaria 7
HU - Ungheria 7
LB - Libano 7
GE - Georgia 6
GH - Ghana 6
HN - Honduras 6
NO - Norvegia 6
PS - Palestinian Territory 6
SY - Repubblica araba siriana 6
AM - Armenia 5
BO - Bolivia 5
CR - Costa Rica 5
CY - Cipro 5
DO - Repubblica Dominicana 5
HR - Croazia 5
JM - Giamaica 5
MT - Malta 5
OM - Oman 5
QA - Qatar 5
RO - Romania 5
SC - Seychelles 5
DK - Danimarca 4
KG - Kirghizistan 4
KW - Kuwait 4
LK - Sri Lanka 4
LU - Lussemburgo 4
LV - Lettonia 4
MW - Malawi 4
SN - Senegal 4
Totale 41.741
Città #
Southend 2.313
Dallas 2.000
Dublin 1.985
Fairfield 1.503
Singapore 1.472
Ashburn 1.259
Chandler 1.132
Moscow 863
Jacksonville 779
Woodbridge 777
Santa Clara 750
Beijing 664
Hong Kong 664
Seattle 642
Wilmington 626
Houston 581
Cambridge 538
Hefei 515
Ann Arbor 512
Siena 505
San Jose 503
Seoul 404
Princeton 341
Nanjing 271
Ho Chi Minh City 270
Johannesburg 269
Los Angeles 263
New York 244
Helsinki 243
Menlo Park 234
The Dalles 233
Lauterbourg 225
Hanoi 213
Milan 204
Munich 194
Council Bluffs 161
Boardman 132
São Paulo 122
San Mateo 116
Buffalo 112
Rome 107
Florence 101
Nanchang 97
San Diego 93
London 78
Fremont 75
Orem 73
Abuja 71
Shanghai 71
Frankfurt am Main 68
Redondo Beach 68
Dong Ket 67
Abidjan 65
Turku 63
Warsaw 61
Dearborn 57
Málaga 57
Bengaluru 56
Shenyang 54
Hebei 53
Brussels 52
Chicago 51
Tianjin 50
Chennai 47
Izmir 47
Da Nang 45
Tokyo 45
Rio de Janeiro 43
Toronto 43
Lappeenranta 41
Changsha 39
Montreal 39
Norwalk 38
San Francisco 37
Atlanta 36
Haiphong 36
Guangzhou 35
Columbus 34
Lancaster 34
Nuremberg 34
Vienna 33
Düsseldorf 32
Jiaxing 32
Kunming 32
Venezia 31
Baghdad 29
Washington 29
Brooklyn 28
Phoenix 28
Stockholm 28
Tashkent 26
Porto Alegre 25
Belo Horizonte 24
Jinan 24
Amsterdam 23
Dhaka 23
Brasília 22
Poplar 22
Manchester 21
Denver 20
Totale 27.627
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 392
A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease 376
Immune response analysis to Measles virus in subjects vaccinated with MMR vaccine and naturally infected subjects. 362
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 360
Anti-angiogenetic effects of immune-reconstituted influenza virosomes assembled with parathyroid hormone-related protein derived peptide vaccine. 347
ANDAMENTO LONGITUDINALE DI BIOMARKERS DI INFIAMMAZIONE ED IMMUNOATTIVAZIONE IN PAZIENTI SOTTOPOSTI A TRAPIANTO DI RENE: UN RUOLO DELLA REPLICAZIONE DI CMV? 346
Valutazione di un test in chemiluminescenza per la diagnosi sierologica di Leishmaniosi Viscerale 342
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients 333
ERITEMA NODOSO RECIDIVANTE E PERSISTENTE REPLICA DI EPSTEIN-BARR VIRUS 332
Plasmablastic transformation of a pre-existing plasmacytoma: a possible role for reactivation of Epstein Barr virus infection. 317
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 317
Peripheral biomarkers' panel for severe COVID-19 patients 316
Non-granulomatous cerebellar infection by Acanthamoeba spp. in an immunocompetent host 314
Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon cancer patients. 300
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 296
Analisi retrospettiva su infezioni invasive e non invasive da batteri Gram negativi non fermentanti in pazienti ospedalizzati 289
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 285
Non-HCV-related cryoglobulinemic vasculitis and parvovirus-B19 infection 284
HCMV infection in renal transplant recipients: a retrospective cohort study 279
Antibody response to SARS-CoV-2 in infected patients with different clinical outcome 277
Un rarissimo caso di infestazione parassitaria cerebellare da Acanthamoeba spp. In soggetto immunocompetente: primo caso in Italia. 273
Analysis of genetic and viral determinants of HBsAg levels in patients with chronic HBV infection 270
Immunization with Toscana virus N-Gc proteins protects mice against virus challenge 268
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 265
Seroprevalence of hepatitis E virus (HEV) infection in blood donors and renal transplant recipients: a retrospective study from central Italy [Sieroprevalenza dell’infezione da virus dell’epatite E (HEV) in donatori di sangue e pazienti trapiantati di rene: Uno studio retrospettivo dal centro Italia] 265
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 264
Peptidi epitopici immunogenici del CEA da utilizzare nella chemio-immunoterapia del carcinoma del colon-retto e della mammella. 261
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 254
Beyond the biological effect of a chemically characterized poplar propolis: Antibacterial and antiviral activity and comparison with flurbiprofen in cytokines release by LPS-stimulated human mononuclear cells 254
Cetuximab +/- chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro 253
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 251
5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine 250
In vitro neuraminidase inhibitory effect and activity against influenza virus A H1N1 of herbal drugs used for common cold 249
Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience 247
Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020 247
Serial KL-6 measurements in COVID-19 patients 246
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 244
Chemotherapeutic drugs may be used to enhance the killing efficacy of human tumor antigen peptide-specific CTLs. 241
Dendritic cell-cediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro 240
EBV Reactivation and Chromosomal Polysomies: Euphorbia tirucalli as a Possible Cofactor in Endemic Burkitt Lymphoma. 237
FIBRILLO-FLUTTER IN ASSENZA DI SEGNI DI MIOCARDITE IN CORSO DI INFEZIONE DA EBV 231
Testicular involvement during Toscana-virus infection: an unusual manifestation? 231
Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers 230
Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects 226
Biotechnology for virus vaccine design, production, and control 225
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 224
Antibody response to wild rubella virus structural proteins following immunization with RA 27/3 live attenuated vaccine 224
Comparison of a new prototype immunochromatographic assay and a commercial enzyme-linked immunosorbent assay for the detection of serum antibodies against Toscana virus 224
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis 223
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine 223
Efficient delivery of DNA to dendritic cells mediated by influenza virosomes 219
Fast duplex one-step RT-PCR for rapid differential diagnosis of entero- or toscana virus meningitis 217
A Poly-epitopic peptide vaccine against the thymidylate synthase (TS). A synergistic therapeutic combination with fluoropyrimidine-based-chemotherapy 216
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 214
Anatomy of an extensively drug-resistant Klebsiella pneumoniae outbreak in Tuscany, Italy 214
Diagnostic tools for Toscana virus infection 213
SARS-CoV-2 in pleural fluid in a kidney transplant patient 213
Seroprevalence to measles virus after vaccination or natural infection in an adult population, in Italy 213
Identification of a neutralizing epitope on tosv gn glycoprotein 212
Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis 212
Detection of asymptomatic SARS-CoV-2 infections among healthcare workers: Results from a large-scale screening program based on rapid serological testing 210
Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients 209
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female 208
Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients 207
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial) 206
Compartimentalizzazione di HCMV: mancata appropiatezza della sola DNAemia nella diagnosi e nella terapia di una polmonite da HCMV post-trapianto polmonare 205
Retrospective diagnosis of West Nile virus infection in a patient with meningoencephalitis in Tuscany, Italy 203
Toscana virus induces interferon although its NSs protein reveals antagonistic activity. 202
Effetti della dieta sulla secrezione di calcitonina nel neonato [The effects of diet on the secretion of calcitonin in the newborn infant] 201
Virosoma dell'influenza immunoricostituito (IRIV) contenente il gene per CD40L come immunoprotettore tumorale CEA-specifico e usi immunogenici di esso. 199
Human Polymorphonuclear Cells Support Zika Virus to Cross Endothelial Monolayer and Access Bloodstream 199
Synthetic peptides of rubella E1 glycoprotein for serological assays 197
Infection prevention in endoscopy practice; comparative evaluation of reusable vs single use endoscopic valves 197
Chemo-immunotherapy of colo-rectal cancer: Drug induced antigen specific cell-mediated immune response in vitro and in cancer patients 196
A Mediterranean arbovirus: the Toscana virus 196
Pathogenic mechanism of Helicobacter pylori: production of cytoxin 196
A Polyepitope DNA Vaccine Targeted to Her-2/ErbB-2 Elicits a Broad Range of Human and Murine CTL Effectors to Protect against Tumor Challenge 196
Applications of Influenza Virosomes as a delivery system 195
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120 195
Age-dependent seroprevalence of Toscana virus in central Italy and correlation with the clinical profile 195
Detection of RSV Genome in Cerebrospinal Fluid of a Patient with Guillain Barrè Syndrome: A Case Report 194
Seroprevalence of antibodies to Sandfly fever Sicilian virus in a sample population in Tuscany, Italy 190
Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine 189
Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector 188
Development of a mouse model for the study of Toscana virus pathogenesis 187
Omicron infection evokes cross-protection against SARS-CoV-2 variants in vaccinees 186
Toscana Virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I. 183
Efficient inactivation of sars-cov-2 and other rna or dna viruses with blue led light 182
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID 180
Epidemiological and clinical study of viral respiratory tract infections in children from Italy 180
ACKNOWLEDGEMENT OF REVIEWERS 180
Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein 176
Immunological characterization of Respiratory Syncytial Virus N protein epitopes recognized by human cytotoxic T lymphocytes 176
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection 176
Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them. 175
Peripheral lymphocyte subset monitoring in COVID-19 Italian patients 174
Rapid identification of Toscana virus by nested PCR during an outbreak in the Siena area of Italy 174
Comparative performance of a new sars-cov-2 rapid detection system 174
Comparative study of the immune response in mice immunized with four live attenuated strains of mumps virus by intranasal or intramuscular route. 173
Neutralizing antibody response of vaccinees to SARS-CoV-2 variants 172
Totale 23.568
Categoria #
all - tutte 127.898
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.898


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021847 0 0 0 0 0 0 0 0 0 288 276 283
2021/20222.608 163 273 146 205 127 89 122 143 219 283 250 588
2022/20234.095 254 328 514 544 417 822 81 350 426 103 168 88
2023/20243.152 111 108 270 180 102 824 1.081 76 18 77 68 237
2024/20256.405 182 357 559 344 721 356 307 377 560 280 650 1.712
2025/202613.604 1.166 2.127 1.597 1.799 2.733 622 1.663 543 585 769 0 0
Totale 42.271